OHE at AES: Medicines Prices in the UK, Health Inequalities in Costa Rica
OHE’s participation at the 33rd Meeting of the Spanish Health Economics Association (AES) last week reported the results of four research projects. Jorge Mestre-Ferrandiz, OHE’s Director of Consulting,...
View ArticleOHE at iHEA: HTA in Emerging Markets, Personalised Medicine, EQ-5D mapping
OHE was involved in several sessions at the 9th World Congress of the International Heath Economics Association (iHEA). Prof Adrian Towse, OHE’s Director, and Prof Lou Garrison, OHE Visiting Senior...
View ArticleClik here to view.
Initial Findings from Research on an EQ-5D-5L Value Set for England
Prof Devlin As reported earlier, OHE’s Prof Nancy Devlin and Prof Ben van Hout of the University of Sheffield were awarded a £457,000 grant from the Policy Research Programme (PRP) of the UK’s National...
View ArticleBenefiting from the Promise of Personalised Medicine: Recent OHE Presentations
OHE’s Adrian Towse participated in a two-day workshop convened by the Biotherapy Development Association to discuss the process and problems that surround decisions about pricing and reimbursement for...
View ArticleOHE Models Incentives for Antibiotic Drug Development
A new model aimed at encouraging the development of new antibiotics was presented[1] recently by OHE’s Chris Hoyle, who collaborated with Adrian Towse and Jorge Mestre-Ferrandiz in designing the model....
View ArticleSpotlight on OHE: NICE, Biosimilars, HTA
OHE’s active involvement in a number of recent conferences and meetings has contributed to discussions on a range of important issue in health economics. Changes in NICE decision making The...
View ArticleClik here to view.
Spotlight on OHE: Competition in the NHS, HESG, Publications
OHE was active in several forums in June. This blog post summarises the highlights. Competition in the NHS Jon Sussex was a keynote speaker at the Capita conference on competition in health care held...
View ArticleClik here to view.
Generating EQ-5D-5L Values in the UAE with TTO and DCE: Initial Results
Shah and Papadimitropolous at ISPOR Asia Pacific As reported in this blog in November 2013, OHE’s Professor Nancy Devlin and Koonal Shah have been working on-site in Abu Dhabi to establish a new...
View ArticleSpotlight on OHE: Innovation, Regulation and Antibiotics
OHE long has been involved in analysing the nature of innovation and the effects of regulation. Two recent OHE presentations address the core issues. Incentives for innovation in antibiotics The...
View ArticleClik here to view.
Towse at ISPOR: Macro HTA and Managed Entry Agreements
Adrian Towse, currently President of ISPOR, contributed to two session at the recent ISPOR Asia-Pacific conference. Using HTA to maximise health system performance Health technology assessment (HTA) is...
View Article
